Study: Mozobil plus protein helps generate stem cells

01/9/2009 | Reuters

U.K. scientists found that mice that received a combination of Genzyme's Mozobil, a transplantation drug, and the VEGF growth factor produced about 100 times more endothelial and mesenchymal stem cells into the bloodstream compared with those that did not undergo the treatment. The technique could be used to treat autoimmune disorders such as rheumatoid arthritis, researchers said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC